PM8002 or Placebo Plus Nab-Paclitaxel as First-line Treatment in Inoperable Locally Advanced/Metastatic TNBC

NCT06419621 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

360

Enrollment

INDUSTRY

Sponsor class

Conditions

Triple Negative Breast Cancer(TNBC)

Interventions

DRUG: PM8002
DRUG: Nab-Paclitaxel
DRUG: Placebo

Sponsor

Biotheus Inc.